Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin
About Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
2
Hoffmann-La Roche
2
Clinical Trials at Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin
During the past decade, Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy
2014-03-11
2019-01-09
Completed
1,225
Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice
2015-02-20
2023-12-31
Recruiting
150
Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Diagnosed Multiple Myeloma (MM) Transplant Ineligible Patients
2017-06-30
2022-08-31
Active, not recruiting
29
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin
According to Clinical.Site data, the most researched conditions in "Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin" are
"Multiple Myeloma" (2 trials), "Breast Cancer" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin" in a lesser frequency.
Clinical Trials Intervention Types at Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin
Most popular intervention types in "Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (2 trials), "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials), "Bortezomib" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin
The vast majority of trials in "Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin" are
4 trials for "All" genders.
Clinical Trials Status at Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin
Currently, there are NaN active trials in "Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".